KR20140129306A - 디안히드로갈락티톨 중의 불순물을 분석 및 결정하기 위한 개선된 분석 방법 - Google Patents
디안히드로갈락티톨 중의 불순물을 분석 및 결정하기 위한 개선된 분석 방법 Download PDFInfo
- Publication number
- KR20140129306A KR20140129306A KR1020147027029A KR20147027029A KR20140129306A KR 20140129306 A KR20140129306 A KR 20140129306A KR 1020147027029 A KR1020147027029 A KR 1020147027029A KR 20147027029 A KR20147027029 A KR 20147027029A KR 20140129306 A KR20140129306 A KR 20140129306A
- Authority
- KR
- South Korea
- Prior art keywords
- dianhydrogalactitol
- ammonium
- formulation
- group
- volatile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- AAFJXZWCNVJTMK-GUCUJZIJSA-N (1s,2r)-1-[(2s)-oxiran-2-yl]-2-[(2r)-oxiran-2-yl]ethane-1,2-diol Chemical compound C([C@@H]1[C@H](O)[C@H](O)[C@H]2OC2)O1 AAFJXZWCNVJTMK-GUCUJZIJSA-N 0.000 title claims abstract description 89
- 229950000758 dianhydrogalactitol Drugs 0.000 title claims abstract description 89
- 239000012535 impurity Substances 0.000 title claims abstract description 54
- 238000004458 analytical method Methods 0.000 title claims abstract description 20
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 63
- 238000000034 method Methods 0.000 claims abstract description 63
- 239000000203 mixture Substances 0.000 claims abstract description 51
- 238000009472 formulation Methods 0.000 claims abstract description 47
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 31
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 17
- 238000001514 detection method Methods 0.000 claims abstract description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 96
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 32
- 239000005695 Ammonium acetate Substances 0.000 claims description 32
- 229940043376 ammonium acetate Drugs 0.000 claims description 32
- 235000019257 ammonium acetate Nutrition 0.000 claims description 32
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 31
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims description 30
- 150000003863 ammonium salts Chemical class 0.000 claims description 29
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 28
- 239000000908 ammonium hydroxide Substances 0.000 claims description 28
- 238000010828 elution Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 238000000149 argon plasma sintering Methods 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 14
- 239000007857 degradation product Substances 0.000 claims description 13
- 238000000105 evaporative light scattering detection Methods 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 10
- 238000003556 assay Methods 0.000 claims description 10
- 239000000356 contaminant Substances 0.000 claims description 7
- 238000001704 evaporation Methods 0.000 claims description 7
- 230000008020 evaporation Effects 0.000 claims description 7
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 claims description 6
- 238000005481 NMR spectroscopy Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 230000015556 catabolic process Effects 0.000 claims description 5
- 150000001793 charged compounds Chemical class 0.000 claims description 5
- 238000006731 degradation reaction Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000003109 Karl Fischer titration Methods 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 150000004679 hydroxides Chemical class 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 229940126534 drug product Drugs 0.000 description 7
- 239000000825 pharmaceutical preparation Substances 0.000 description 7
- 238000010829 isocratic elution Methods 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 229940088679 drug related substance Drugs 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000001448 refractive index detection Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000012899 standard injection Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 1
- 206010014952 Eosinophilia myalgia syndrome Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000023077 detection of light stimulus Effects 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/74—Optical detectors
- G01N2030/743—FTIR
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8872—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample impurities
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/74—Optical detectors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/203332—Hydroxyl containing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Spectroscopy & Molecular Physics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261603464P | 2012-02-27 | 2012-02-27 | |
| US61/603,464 | 2012-02-27 | ||
| PCT/IB2013/000793 WO2013128285A2 (en) | 2012-02-27 | 2013-02-26 | Improved analytical methods for analyzing and determining impurities in dianhydrogalactitol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20140129306A true KR20140129306A (ko) | 2014-11-06 |
Family
ID=49083394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147027029A Ceased KR20140129306A (ko) | 2012-02-27 | 2013-02-26 | 디안히드로갈락티톨 중의 불순물을 분석 및 결정하기 위한 개선된 분석 방법 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10145824B2 (enExample) |
| EP (1) | EP2820408A4 (enExample) |
| JP (1) | JP6223364B2 (enExample) |
| KR (1) | KR20140129306A (enExample) |
| CN (1) | CN104428664B (enExample) |
| AU (1) | AU2013227353B2 (enExample) |
| BR (1) | BR112014021163A2 (enExample) |
| CA (1) | CA2865709A1 (enExample) |
| CL (1) | CL2014002276A1 (enExample) |
| HK (1) | HK1208528A1 (enExample) |
| MX (1) | MX2014010312A (enExample) |
| SG (1) | SG11201405249QA (enExample) |
| WO (1) | WO2013128285A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1208528A1 (en) | 2012-02-27 | 2016-03-04 | 德马医药 | Improved analytical methods for analyzing and determining impurities in dianhydrogalactitol |
| MX2016006457A (es) * | 2013-11-18 | 2017-01-06 | Del Mar Pharmaceuticals | Analisis de cromatografia liquida de alto rendimiento (hplc) de impurezas en dianhidrogalactitol. |
| CN108699018B (zh) * | 2015-11-25 | 2022-08-12 | 德玛医药（Bc）有限公司 | 双脱水半乳糖醇和其衍生物或类似物的制剂的分析和分辨方法 |
| JP6954644B2 (ja) | 2016-04-04 | 2021-10-27 | 国立大学法人三重大学 | アルギン酸リアーゼ及び当該酵素を用いる不飽和ウロン酸単糖の製造方法 |
| CN106596751B (zh) * | 2016-11-04 | 2020-05-19 | 天津大学 | 一种氯代消毒副产物二氯乙酰胺和三氯乙酰胺的高效液相色谱-电喷雾质谱检测方法 |
| JP6988158B2 (ja) * | 2017-05-11 | 2022-01-05 | 株式会社島津製作所 | 液体クロマトグラフ質量分析方法及び液体クロマトグラフ質量分析装置 |
| CN108827998B (zh) * | 2018-05-30 | 2021-06-22 | 中国计量科学研究院 | 一种采用定量核磁共振氢谱准确测量易挥发性物质纯度的方法 |
| WO2021038417A1 (en) * | 2019-08-30 | 2021-03-04 | Dh Technologies Development Pte. Ltd. | Method for mass spectrometry |
| EP4083620B1 (en) * | 2021-04-30 | 2025-03-05 | F. Hoffmann-La Roche AG | Lc system and method with column backflushing |
| JP2023138462A (ja) | 2022-03-16 | 2023-10-02 | 国立大学法人三重大学 | ４－デオキシ－ｌ－エリスロ－５－ヘキソセウロース・ウロン酸の新規用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04297868A (ja) | 1991-03-27 | 1992-10-21 | Tonen Corp | オリゴ糖の分析方法 |
| JPH09229920A (ja) * | 1996-02-26 | 1997-09-05 | Kao Corp | グラジェント液体クロマトグラフィー溶離液の処理方法 |
| US6060525A (en) | 1996-03-01 | 2000-05-09 | Dionix Corporation | Removal of borate in chromatography |
| US20030060434A1 (en) | 1997-02-18 | 2003-03-27 | Loretta Nielsen | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| WO2000042225A1 (en) | 1999-01-14 | 2000-07-20 | Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College | Process for the separation of sugars |
| US20020037328A1 (en) * | 2000-06-01 | 2002-03-28 | Brown Dennis M. | Hexitol compositions and uses thereof |
| US20060148732A1 (en) | 2000-11-17 | 2006-07-06 | Gutterman Jordan U | Inhibition of NF-kappaB by triterpene compositions |
| US20030229237A1 (en) * | 2002-04-02 | 2003-12-11 | Haas Michael J. | In situ production of fatty acid alkyl esters |
| JP2004294384A (ja) | 2003-03-28 | 2004-10-21 | National Agriculture & Bio-Oriented Research Organization | １−デオキシノジリマイシンの測定方法 |
| EP1660039B1 (en) | 2003-07-18 | 2016-09-28 | Oakwood Laboratories L.L.C. | Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| WO2005114171A2 (en) | 2004-05-20 | 2005-12-01 | Chiron Srl | Analysis of liquid chromatography eluates |
| JP2008076340A (ja) | 2006-09-25 | 2008-04-03 | Toppan Printing Co Ltd | 高感度検出方法およびその検出装置 |
| WO2011092120A1 (en) * | 2010-01-29 | 2011-08-04 | Nerviano Medical Sciences S.R.L. | 6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators |
| US8563758B2 (en) | 2010-08-18 | 2013-10-22 | Del Mar Pharmaceuticals | Method of synthesis of substituted hexitols such as dianhydrogalactitol |
| HK1208528A1 (en) | 2012-02-27 | 2016-03-04 | 德马医药 | Improved analytical methods for analyzing and determining impurities in dianhydrogalactitol |
| US9029164B2 (en) * | 2012-02-27 | 2015-05-12 | Del Mar Pharmaceuticals | Analytical methods for analyzing and determining impurities in dianhydrogalactitol |
-
2013
- 2013-02-26 HK HK15109084.1A patent/HK1208528A1/xx unknown
- 2013-02-26 JP JP2014558224A patent/JP6223364B2/ja not_active Expired - Fee Related
- 2013-02-26 CN CN201380022154.4A patent/CN104428664B/zh not_active Expired - Fee Related
- 2013-02-26 MX MX2014010312A patent/MX2014010312A/es unknown
- 2013-02-26 CA CA2865709A patent/CA2865709A1/en not_active Abandoned
- 2013-02-26 US US14/380,924 patent/US10145824B2/en active Active
- 2013-02-26 AU AU2013227353A patent/AU2013227353B2/en not_active Ceased
- 2013-02-26 EP EP13754722.0A patent/EP2820408A4/en not_active Withdrawn
- 2013-02-26 WO PCT/IB2013/000793 patent/WO2013128285A2/en not_active Ceased
- 2013-02-26 SG SG11201405249QA patent/SG11201405249QA/en unknown
- 2013-02-26 KR KR1020147027029A patent/KR20140129306A/ko not_active Ceased
- 2013-02-26 BR BR112014021163-9A patent/BR112014021163A2/pt not_active Application Discontinuation
- 2013-07-02 US US13/933,844 patent/US9759698B2/en not_active Expired - Fee Related
-
2014
- 2014-08-27 CL CL2014002276A patent/CL2014002276A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10145824B2 (en) | 2018-12-04 |
| WO2013128285A3 (en) | 2013-12-27 |
| CA2865709A1 (en) | 2013-09-06 |
| HK1208528A1 (en) | 2016-03-04 |
| JP6223364B2 (ja) | 2017-11-01 |
| CL2014002276A1 (es) | 2014-12-19 |
| AU2013227353B2 (en) | 2016-06-09 |
| JP2015508174A (ja) | 2015-03-16 |
| CN104428664A (zh) | 2015-03-18 |
| MX2014010312A (es) | 2015-04-14 |
| WO2013128285A9 (en) | 2014-02-27 |
| CN104428664B (zh) | 2018-09-21 |
| US20140017798A1 (en) | 2014-01-16 |
| WO2013128285A2 (en) | 2013-09-06 |
| AU2013227353A1 (en) | 2014-09-25 |
| US9759698B2 (en) | 2017-09-12 |
| EP2820408A4 (en) | 2015-11-18 |
| SG11201405249QA (en) | 2014-10-30 |
| BR112014021163A2 (pt) | 2020-10-27 |
| US20150027206A1 (en) | 2015-01-29 |
| EP2820408A2 (en) | 2015-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10145824B2 (en) | Analytical methods for analyzing and determining impurities in dianhydrogalactitol | |
| JP2015508174A5 (enExample) | ||
| US9029164B2 (en) | Analytical methods for analyzing and determining impurities in dianhydrogalactitol | |
| KR20160108315A (ko) | 디안히드로갈락티톨 중의 불순물의 ｈｐｌｃ 분석 | |
| Zhou et al. | Hydrophilic interaction ultra-performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry for highly rapid and sensitive analysis of underivatized amino acids in functional foods | |
| Abdulla et al. | Hydrophilic interaction chromatography analysis of esculin in ointments with UV detection | |
| Wei et al. | A sensitive and selective UPLC–MS/MS method for simultaneous determination of 10 alkaloids from Rhizoma Menispermi in rat plasma and its application to a pharmacokinetic study | |
| Jeong et al. | A sensitive UPLC–ESI–MS/MS method for the quantification of cinnamic acid in vivo and in vitro: application to pharmacokinetic and protein binding study in human plasma: S. Jeong et al. | |
| US10591445B2 (en) | Methods for analysis and resolution of preparations of dianhydrogalactitol and derivatives or analogs thereof | |
| CN106483226B (zh) | 一种高效液相色谱分离六神丸紫外吸收成分的方法 | |
| Yang et al. | Comparative pharmacokinetics with single substances and Semen Cuscutae extract after oral administration and intravenous administration Semen Cuscutae extract and single hyperoside and astragalin to rats | |
| SAITO et al. | Simultaneous determination of slimming drugs in dietary supplements by liquid chromatography/time-of-flight mass spectrometry | |
| Ioutsi et al. | Determination of Pharmacologically Active Nitrogen-Containing Compounds on Silica Doubly Modified with 6, 10-Ionene and Dextran Sulphate by High-Performance Liquid Chromatography–Tandem Mass Spectrometry | |
| Ouyang et al. | Determination of ephedrine and related compounds in pharmaceutical preparations by ion chromatography with direct conductivity detection | |
| Tian et al. | Determination of shionone in rat plasma by HPLC and its pharmacokinetic study | |
| CN107478757B (zh) | 用于法庭科学毒品检测的氯胺酮标准物质的纯化制备方法 | |
| Baghel et al. | HPLC separation of Pidotimod enantiomers using beta-cyclodextrin based chiral stationary phase | |
| Nieddu et al. | Investigation on gabapentin residues in eggs from free-range hens exposed to saline slags from pharmaceutical industry | |
| CN106353154A (zh) | 丙氨酰谷氨酰胺注射液中一个四肽类杂质的分离制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20140925 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20180223 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190712 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20190925 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20190712 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |